ALK and anaplastic large cell lymphoma: Several retrospective studies have shown that long-term survival of most PTCL do not exceed 30–40%, with systemic anaplastic large cell lymphoma (ALCL) expressing the anaplastic large cell lymphoma kinase (ALK) protein being the exception[1–4].